While sampling may seem like a routine operational activity, it is one of the most important components of a pharmaceutical quality system. Accurate and representative sampling provides the data necessary to confirm utility performance, support regulatory compliance, and protect patient safety. Conversely, poor sampling practices can generate misleading results, unnecessary investigations, and potentially significant quality risks.
At its most basic level, sampling involves collecting a small portion of a larger system stream and using it to represent the condition of the entire system. In practice, however, obtaining a truly representative sample is far more complex than it appears.
Multiple variables can influence sample integrity, including:
- Environmental conditions
- Sampling techniques and operator practices
- Sampling valve design and configuration
- Collection container selection
- Sample handling, transportation, and storage conditions
- Time elapsed between collection and analysis
Even minor deviations in these factors can alter sample quality and compromise analytical results. The consequence is data that may no longer accurately reflect the true condition of the utility system.
The updated ISPE Good Practice Guide: Sampling for Pharmaceutical Water, Steam, and Process Gases, (Second Edition) emphasizes that effective sampling is not simply a laboratory activity. It is a controlled process requiring scientific rigor, standardized procedures, and a thorough understanding of system behavior.
The Guide is intended to:
- Provide industry standards and best practices in a single comprehensive reference
- Clarify which quality attributes should be determined through sampling versus validated instrumentation
- Help minimize sampling errors that could threaten patient safety
- Reduce sampling-related contributions to out-of-specification results
Improper sampling can have serious operational and compliance consequences.
Perhaps even more concerning, poor sampling practices can mask actual quality issues. In these cases, contaminated or out-of-specification utilities may go undetected, potentially affecting product quality and patient safety.
Both scenarios carry significant business implications, including:
- Regulatory observations
- Increased compliance risk
- Damage to organizational reputation
- Financial losses from remediation activities
- Reduced confidence in quality systems
For these reasons, sampling programs must be designed to minimize variability and maximize confidence in the data generated.
Regulatory agencies and industry organizations consistently stress the importance of reliable sampling practices.
Guidance from the US Food and Drug Administration, along with standards such as USP <1231> Water for Pharmaceutical Purposes, highlights the need for scientifically sound sampling methods that accurately characterize utility systems. Improperly collected samples may produce inaccurate conclusions regarding system performance, resulting in flawed decision-making and potential compliance concerns.
To meet these expectations, organizations should develop sampling programs that emphasize:
- Consistency
- Traceability
- Repeatability
- Data integrity
- Scientific justification
Robust sampling practices help ensure that analytical results accurately reflect actual utility conditions and support defensible quality decisions.
The second edition of the ISPE Guide specifically addresses which utility attributes are best evaluated through traditional sampling and which can be effectively monitored using validated process instrumentation.
Building a Risk-Based Sampling Program
An effective sampling program should never be static. Instead, it should evolve based on system performance, operational experience, and emerging technologies.
A risk-based approach involves evaluating:
- Historical monitoring data
- Utility system design
- Criticality of use points
- Process requirements
- Failure modes and trends
- Regulatory expectations
Using these insights, organizations can optimize:
- Sampling frequencies
- Sample locations
- Alert limits
- Action limits
- Investigation procedures
The revised edition reflects significant changes in both industry practice and regulatory expectations. Updates include:
- Alignment with current regulations and industry standards
- Incorporation of technological advancements
- Expanded discussion of laboratory practices
- Improved organization and usability
- Reduction of duplicated content from the original edition
- A more modular structure consistent with other ISPE guidance documents
Importantly, it remains the only comprehensive guide dedicated exclusively to the sampling of pharmaceutical water, steam, and process gases.
In today's highly regulated pharmaceutical environment, effective sampling is far more than a technical procedure. It is a strategic quality function that directly influences patient safety, regulatory compliance, operational efficiency, and business performance.
By implementing scientifically sound sampling practices, adopting risk-based monitoring strategies, and leveraging modern analytical technologies, pharmaceutical organizations can significantly reduce variability, strengthen data integrity, and improve confidence in utility system performance.
As utility systems continue to evolve, organizations that prioritize sampling excellence will be better positioned to maintain control, ensure compliance, and consistently deliver high-quality products to patients worldwide.
Get the Guide
